Articulate Isn't Dead. The Authoring Tool Debate Is Just Getting Started.

Apparently we have to declare a software platform dead every time a competitor releases an impressive demo. I'd rather retire that argument and have a more useful one.

A tool is a set of tradeoffs

Articulate Storyline and Rise have real strengths and real constraints. So do AI-native tools. One workflow may make it easier to assemble a first draft. Another may offer the interaction control, review process or publishing behavior a team already depends on. Neither a familiar brand nor a dramatic product launch tells you whether a tool fits your environment.

Start with the delivery reality

Does the experience need SCORM or xAPI support? How does it behave inside the target LMS? Can reviewers make accurate changes without breaking interactions? What are the accessibility expectations? Can teams localize it, govern templates, enforce branding and troubleshoot issues after launch? Those are not excuses to avoid innovation. They are design constraints. Ignore them and somebody else inherits the ugly parts later.

Test before switching

Choose a representative project, not the easiest possible demo. Build and test it in the existing platform and the proposed replacement. Compare authoring time, publishing behavior, accessibility defects, review cycles, maintenance work and vendor lock-in. Articulate isn't entitled to permanent loyalty. No vendor is. But neither does a competitor earn the right to replace it by creating a good-looking sample in two minutes. The authoring-tool debate should get more specific, not louder.